I’ve spent the last 15 years developing therapies using bone mesenchymal stem cells for treatment of neurological injury and disease. Over these years, preclinical research of mine and others has translated to over 500 clinical trials currently employing these cells for treatment of stroke, heart disease, dementia, and more.
This is especially good news when it comes to diseases such as ischemic stroke, where we haven’t had a new approved therapeutic in over 20 years. It is no exaggeration to say that stem cell therapy is creating opportunities for treatment where few existed.
However, there is a problem. To put it simply: 1) Your own stem cells treat you best, 2) your stem cells decline with age, and 3) you need your stem cells most for diseases that affect you when you are old.
Our solution is to cryopreserve your stem cells now, creating a reservoir of youthful stem cells that you draw upon throughout your life.
In addition, we are developing applications for these cells that not only treat age-related disease, but actually delay their onset.
Of course, few matters in biology and medicine can be “simply put”, and we’d be happy to discuss details below!
by Andrey
Azimov